-
ApexPrep DNA Plasmid Miniprep Kit for AML Assays
2026-08-30
The ApexPrep DNA Plasmid Miniprep Kit supports molecular biology grade plasmid DNA preparation for mechanistic AML research. This article connects alkaline lysis workflow design with the LMO2/LDB1 findings that guide perturbation, rescue, and orthogonal assay decisions.
-
Daphnepedunin A Targets Cdc42 in Kidney Fibrosis
2026-08-29
The 2024 Advanced Science study identifies daphnepedunin A as a natural small molecule that suppresses kidney fibrosis by targeting Cdc42-mediated GSK-3β/β-catenin signaling. Its combination of phenotypic screening, thermal proteome profiling, cellular validation, and unilateral ureteral obstruction experiments provides a useful framework for discovering mechanism-based antifibrotic compounds.
-
AM 281: CB1 Antagonist Research Workflow
2026-08-29
AM 281 enables selective interrogation of CB1 signaling in assays that connect endocannabinoid activity with astrocytic GLT-1, neuronal survival, and cognition. Its high CB1-versus-CB2 affinity makes it especially useful for mechanistic neuropharmacology workflows spanning traumatic brain injury, memory impairment research, and addiction-related models.
-
BKT140 (BL-8040) CXCR4 Antagonist Guide
2026-08-28
BKT140, also called BL-8040 and TF 14016, is an orally bioavailable CXCR4 antagonist for oncology research. It supports studies of CXCR4-mediated chemotaxis inhibition, tumor microenvironment signaling, apoptosis induction in cancer cells, and hematopoietic stem cell mobilization.
-
G-15 and GPR30: From Signal to Pain Circuit
2026-08-28
G-15 offers a selective way to interrogate GPR30 biology, connecting rapid estrogen-linked signaling with spinal pain circuitry. This thought-leadership guide translates mechanistic evidence into practical assay design, control strategies, and a cautious roadmap for translational researchers.
-
GLT-1–CB1-CREB Signaling in TBI
2026-08-27
A 2025 Biomolecules study identifies a mechanistic link between post-traumatic 2-AG signaling, reduced astrocytic GLT-1, glutamate excitotoxicity, and cognitive dysfunction. Using controlled cortical impact, pharmacological perturbation, behavioral testing, and tissue analyses, the authors show that CB1-CREB pathway inhibition can restore GLT-1 expression and reduce neuronal apoptosis in mice.
-
TPCA-1 for NF-κB Pathway Workflows
2026-08-26
Use TPCA-1 as a selective IKK-2 inhibitor to connect NF-κB activation with cytokine release, miRNA regulation, and inflammatory cell injury. This workflow-oriented guide covers LPS challenge design, renal inflammation assays, arthritis benchmarking, formulation, and troubleshooting.
-
Biotin-tyramide: Mechanism, TSA Workflow, and Limits
2026-08-26
Biotin-tyramide is a biotin phenol–based reagent for HRP-dependent tyramide signal amplification in immunohistochemistry and in situ hybridization. Its localized biotin deposition supports fluorescence or chromogenic readouts, but performance depends on HRP targeting, reagent preparation, and prompt solution use.
-
AG-490: A Translational Probe of JAK2 Signaling
2026-08-25
AG-490, also known as Tyrphostin B42, is more than a catalog-listed kinase inhibitor. Used with appropriate controls, it can help translational researchers test whether exosome-driven macrophage polarization in hepatocellular carcinoma depends on JAK2-linked signaling, while revealing the interpretive limits imposed by its activity against EGFR, ErbB2, JAK3, STAT, and MAPK-associated pathways.
-
Ionic-Liquid Phase Behavior of Coil-Bottlebrush Diblocks
2026-08-25
Rodriguez, Mahanthappa, and Lodge investigate how coil-block-bottlebrush diblock copolymers assemble in coil-selective alkylimidazolium ionic liquids. Their central result is that morphology depends surprisingly weakly on the ionic liquid alkyl-chain length, despite substantial changes in solvent selectivity, providing a useful design principle for lyotropic nanostructured materials.
-
RG108 and the Translational Logic of DNA Demethylation
2026-08-24
RG108 offers translational researchers a direct way to interrogate DNA methyltransferase activity, connect methylation changes with tumor suppressor gene reactivation, and strengthen mechanistic interpretation in cancer research. This thought-leadership perspective places RG108 within the broader preclinical evidence landscape, including the catalpol literature, while distinguishing hypothesis generation from clinical validation.
-
Bestatin (Ubenimex) Workflows for Cancer Research
2026-08-23
Bestatin (Ubenimex) provides a selective way to connect aminopeptidase activity with proteostasis, apoptosis, and multidrug resistance phenotypes. This guide outlines enzyme-first screening, cell-based validation, quantitative controls, and troubleshooting strategies for more interpretable cancer research data.
-
Purmorphamine: A Translational Smoothened Strategy
2026-08-22
Purmorphamine is a Smoothened agonist that gives translational researchers a controllable way to interrogate Hedgehog signaling across osteogenic, neural, and sensory models. This thought-leadership perspective connects Smo mechanism, assay design, cross-species evidence, and strategic validation.
-
WP1066 JAK2/STAT3 Inhibitor Workflows
2026-08-21
WP1066 is a cell-permeable JAK2/STAT3 inhibitor for dissecting oncogenic signaling, apoptosis, and treatment response in renal carcinoma and AML models. Its value also extends to pathway-validation studies prompted by regenerative biomaterials research, where JAK2-STAT3 activation—not inhibition—supports reparative macrophage metabolism.
-
Recombinant Human IL-15 for T and NK Assays
2026-08-20
Build more reproducible T-cell activation, NK-cell proliferation, and cytokine-response workflows with a highly active, tag-free interleukin-15 preparation. This guide connects practical immune-cell assay design with a recent neurobehavioral study while clearly separating established applications from exploratory cross-domain interpretation.
447 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page